JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Discordance of visual and quantitative analysis regarding false negative and false positive test results in thallium-201 myocardial perfusion scintigraphy.

Visual assessment and quantitative analysis of exercise thallium-201 myocardial perfusion scintigraphy was performed in 203 consecutive patients who underwent coronary arteriographic studies to identify the factors associated with false negative and false positive studies. Also the discordance between visual and quantitative analysis was evaluated. One hundred sixty-two (80%) of these 203 patients had significant coronary artery disease (CAD), i.e. a luminal stenosis greater than or equal to 50%. Fifty-two (32%) of these 162 patients with documented CAD showed negative thallium results either by visual or quantitative analysis. When interpreted visually 36/162 (22%) of patients were judged as negative, and when analyzed quantitatively 41/162 (25%) of patients were judged as negative (ns). Of the total group of 52 patients with false negative visual and/or quantitative analysis test results, 27 (17%) showed discordance between these two methods. Of the 41 patients without significant CAD, 12 (29%) showed positive thallium findings. Visual interpretation was positive in 9/41 (22%) of patients without significant CAD, and quantitative analysis in 5/41 (12%) (ns). Of the total group of 12 patients with positive visual and/or quantitative analysis test results, 10 (24%) showed discordance between these two methods. Therefore, in the total group, 37 patients (18%) showed discordance between visual and quantitative analysis. It is concluded that 1) the sensitivity and the specificity of visual interpretation and quantitative analysis of thallium-201 exercise scintigraphy for detecting CAD is similar, and 2) that there is frequent discordance of visual interpretation and quantitative analysis in thallium-201 exercise scintigraphy.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app